Healthcare -
Medical - Devices - NASDAQ - US
$ 3.86
3.49 %
$ 2.75 M
Market Cap
0.05
P/E
RSLS - COST OF REVENUE
Cost of Revenue RSLS - ReShape Lifesciences Inc.
3.13 M
LAST VALUE
-22.80%
2 YEAR CAGR
80.29%
5 YEAR CAGR
0.00%
10 YEAR CAGR